checkAd
    Startseite > Aktien > Ipsen > Nachrichten
    Ipsen Aktie
    121,60
     
    EUR
    +0,58 %
    +0,70 EUR
    Letzter Kurs 20.05.24 Lang & Schwarz
    121,10
     
    EUR
    19 STK
    Geldkurs 20.05.24
    122,10
     
    EUR
    19 STK
    Briefkurs 20.05.24
    ISIN: FR0010259150 · WKN: A0ESMG · Frankreich

    Neueste Nachrichten

    Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
    07.05.24 · globenewswire · Ipsen
    Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
    06.05.24 · globenewswire · Ipsen
    Ipsen appoints Keira Driansky as EVP, President of North America
    02.05.24 · globenewswire · Ipsen
    Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
    24.04.24 · globenewswire · Ipsen
    Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
    22.04.24 · globenewswire · Ipsen
    Ipsen publishes its 2023 Universal Registration Document
    17.04.24 · globenewswire · Ipsen
    Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
    08.04.24 · globenewswire · Ipsen
    Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
    02.04.24 · globenewswire · Ipsen
    Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
    07.03.24 · globenewswire · Ipsen
    Ipsen S.A. publishes its 2023 Consolidated Financial Statements
    15.02.24 · globenewswire · Ipsen
    Ipsen’s Onivyde regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA  
    13.02.24 · globenewswire · Ipsen
    Building on solid FY 2023 results, Ipsen anticipates four launches in 2024
    08.02.24 · globenewswire · Ipsen